An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
2001 · Science · 933 citations
https://doi.org/10.1126/science.1064852
J
Jean‐Charles Fruchart
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
471
Papers
39.8K
Citations
104
h-index
307
i10-index
Jean‐Charles Fruchart is an academic researcher from Risk Engineering (Bulgaria). The author has contributed to research in topics: Peroxisome Proliferator-Activated Receptors & Lipoproteins and Cardiovascular Health & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 104, co-authored 401 publications.
Papers by this author
worksTriglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
2022 · New England Journal of Medicine · 638 citations
https://doi.org/10.1056/nejmoa2210645
Atherogenic Lipoprotein Particles in Atherosclerosis
2004 · Circulation · 493 citations
https://doi.org/10.1161/01.cir.0000131511.50734.44
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
1994 · Journal of Biological Chemistry · 247 citations
https://doi.org/10.1016/s0021-9258(18)47383-8
Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
2013 · Cardiovascular Diabetology · 185 citations
https://doi.org/10.1186/1475-2840-12-82
Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
1992 · Journal of Lipid Research · 175 citations
https://doi.org/10.1016/s0022-2275(20)41415-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat